ArticleInvestigative ophthalmology & visual science2025
Quantitative Choroidal Analysis of Molecularly Characterized Retinitis Pigmentosa.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advances in RPGR gene therapy for X‑linked retinitis pigmentosa: From preclinical insights to clinical application (Review).International journal of molecular medicine · 2026Review
- Retinitis pigmentosa and sensorineural deafness associated with aFrontiers in genetics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Retinitis pigmentosa (RP) is a genetically diverse progressive retinal degeneration with many biomarkers. Detailed retinal phenotypes are described using multimodal imaging, however choroidal characteristics remain ill-defined. We report the first quantitative choroidal evaluation in molecularly characterized RP and assess relationships with retinal structure and function. Methods: Patients with genetically confirmed RP who had optical coherence tomography images and best-corrected visual acuity (BCVA) were assessed. Optical coherence tomography images were manually segmented (ITKSnap) calculating choroidal thickness (CT), choroidal area (CA), and choroidal volume (CV). The choroidal vascularity index (CVI) was calculated with ImageJ. Comparisons were made between X-linked (RPGR), autosomal-recessive (USH2A), and autosomal-dominant (RHO, PRPF31) genotypes, including comparisons for choroidal/retinal parameters, BCVA, and spherical equivalent (SE). Results: Sixty-five patients (mean age, 47.3 ± 19.5 years; 52.3% female) met the inclusion criteria. CT was thinner in RP patients than controls (P = 0.003). A thinner choroid was associated with older age (r = -0.512; P < 0.001) and worse BCVA (r = 0.298, P = 0.002) but not SE (P = 0.194). Although variable, no statistically significant differences were found for choroidal measures between groups. Leptochoroid (≤100 µm) was associated with advanced age (P < 0.001) and worse BCVA (P = 0.032), but not greater myopia (P = 0. 533). Greater CVI was only associated with better BCVA (P < 0.001) and no other parameters. Conclusions: We report the first quantitative choroidal assessment in a cohort with genetically characterized RP. CT changes in RP are not explained solely by age-related choroidal thinning, nor by SE but seem to be dynamic and reactive to degree and rate of retinal degeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.